Purchase Order 75F40124P00206
Award Date
7/25/24
Potential Completion Date
7/30/25
Potential Value
$66K
Federal Agency
Food and Drug Administration
Awardee
Nanostring Technologies, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98109, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Nanostring Technologies, Inc. is for $186,000.00 and was issued by the Office of the Director, a civilian agency. The contract is a purchase order with a firm fixed price and an ultimate completion date of August 30, 2015. Nanostring, a publicly traded provider of advanced genomic analysis platforms and life science tools, has supplied specialized laboratory equipment, reagents, assays, and testing services to support biomedical research and healthcare programs...
This federal contract award, valued at $10,391.01, was issued by the National Institute of Environmental Health Sciences (NIEHS) to Nanostring Technologies, Inc., a publicly held provider of advanced genomic analysis platforms and related life science tools. The contract is for the procurement of laboratory equipment and supplies, with a completion date of November 30, 2024. While the original solicitation is not provided, the award indicates that Nanostring has previously supplied the NIEHS, as...
This is a federal contract award to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools. The contract, valued at $5,883.00, is a firm fixed-price purchase order from the National Institute of Allergy and Infectious Diseases (NIAID) for assay kits. The contract has no set-aside designation. Nanostring has provided a wide range of products and services to various government agencies through past prime and subcontract awards,...
This is a $10,892 firm fixed-price contract awarded by the National Cancer Institute (NCI) to Nanostring Technologies, Inc. for the delivery of specialized laboratory equipment, reagents, assays, and testing services to support genomic, molecular, and cellular analysis for biomedical research and healthcare programs. The contract is a call order under a larger $596,881.45 indefinite delivery/indefinite quantity (IDIQ) contract with the USDA Agricultural Research Service, as well as a $2.8...
This is a $127,500 firm fixed-price Purchase Order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Nanostring Technologies, Inc. for the NanoString nCounter Analysis System. The contract does not have a set-aside designation. Nanostring Technologies is a publicly traded provider of advanced genomic analysis platforms and life science tools. Through this contract, they are supplying specialized laboratory equipment, reagents, assays,...
This $95,320 firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools. The contract is for the delivery of "GENE SETS", with an ultimate completion date of March 30, 2019. Nanostring is a manufacturer of goods and has provided a wide range of products and services to various federal agencies through past prime and...
This federal contract award to Nanostring Technologies, Inc. is a Blanket Purchase Agreement (BPA) Call with the National Cancer Institute, a civilian agency within the Department of Health and Human Services. The contract, valued at $22,280.00, is for the delivery of laboratory equipment, glassware, and supplies to support genomic analysis, with an ultimate completion date of January 27, 2025. Nanostring is a publicly-traded provider of life science tools, including their nCounter Analysis...
This is a $24,999 firm fixed price contract awarded by the National Cancer Institute (part of the National Institutes of Health) to Nanostring Technologies, Inc., a publicly traded provider of specialized genomic analysis equipment and services. The contract is a BPA call, indicating it was issued under a larger Blanket Purchase Agreement. Nanostring will provide the agency with its proprietary nCounter Analysis Systems, GeoMx Digital Spatial Profilers, custom gene expression panels, and related...
This is a firm fixed-price contract awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Nanostring Technologies, Inc. to provide biological and reagent material. The $24,339.03 contract does not have a set-aside designation and will be performed in Seattle, Washington. Nanostring Technologies is a publicly-traded manufacturer of life science tools for translational research and molecular diagnostics, including their nCounter Analysis...
This federal contract award to Nanostring Technologies, Inc. is for the provision of the NANOSTRING HUMAN MIRNA ASSAY KIT, valued at $10,789.01. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract is a firm fixed-price purchase order with a completion date of September 29, 2015. Nanostring Technologies is a publicly traded provider of advanced genomic analysis platforms...